Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier

Antifusogenic proteins comprising human immunodeficiency virus type 1 (HIV-1) gp41 DP-178 polypeptide variants and a macromolecular carrier

US Patent 7988974 · Granted Aug 2, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of a platelet dry powder for relieving inflammation or injury in a portion o2024
Inhibitors of intracellular invasion2024
Inhibitors of intracellular invasion2021
Systems and methods for deep spectroscopic imaging of biological samples with us2017
Meta-Diarylaniline or meta-diarylpyridinamine compound, preparation method and m2016
Anti-HIV agents with dual sites of action2008
Anti-retroviral moronic acid derivatives2007
Nucleic acids encoding DP-178 and other viral fusion inhibitor peptides useful f2007
Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides usef2006
Methods for identification of CDS8+ suppressor molecules2006
Anti-HIV agents with dual sites of action2006
Methods for inhibition of membrane fusion-associated events, including HIV trans2004